Schedule 13G ownership disclosure

Fennec Pharmaceuticals Inc

Security class unavailable · CUSIP: 31447P100

Event date: 2018-06-13

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
5.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001493152-18-009118
Form type
SC 13G
Filer
FENNEC PHARMACEUTICALS INC.
CIK
CIK 1211583
Filed
Jun 22, 2018
Reporting period
Jun 13, 2018
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub